Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis

Recombinant beta interferons-1 (IFNβ-1) are used as first line therapies in patients with relapsing multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the CNS. IFNβ-1a/b has moderate effects on the prevention of relapses and slowing of disease progression. Fibroblast gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Ranjithkumar, Rajendran, Vinothkumar, Gupta, Liza, Shirvanchi, Kian, Schunin, Darja, Karnati, Srikanth, Giraldo-Velásquez, Mario, Berghoff, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603153/
https://www.ncbi.nlm.nih.gov/pubmed/36293040
http://dx.doi.org/10.3390/ijms232012183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603153/
https://www.ncbi.nlm.nih.gov/pubmed/36293040
http://dx.doi.org/10.3390/ijms232012183

Ejemplares similares